Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Tachycardia, Supraventricular 1Heart Failure 1Cardiotoxicity 1Atrial Fibrillation 1Arrhythmias, Cardiac 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1237Docetaxel 1227Oxaliplatin 1184Capecitabine 1176Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 898Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 639Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Gonadal Steroid Hormones × Clear all
NCT07412873 2026-02-17

PROVIDENCE

Fundacion Clinic per a la Recerca Biomédica

Phase 4 Not yet recruiting
120 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT03243604 2018-10-18

ARBITRAGE

Groupe Hospitalier Pitie-Salpetriere

Completed
1,717 enrolled

Arrhythmias, Cardiac, Atrial Fibrillation, Heart Failure, Tachycardia, Supraventricular, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡